cancer Content

Consortium News

The UCLA CTSI's clinical research infrastructure supported the UCLA arm of a multisite study that led  to the FDA's recent approval of larotrectinib, a drug that more

Consortium News

The activity of telomerase is critical to health, affecting aging, cancer and stem cell renewal. But scientific understanding of the enzyme has been limited by a lack of atomic-level models. Now a team led by Juli Feigon, professor of chemistry and biochemistry at UCLA, has reported the highest- more

Consortium News

Melanoma, a relatively rare but deadly skin cancer, has been shown to switch differentiation states -- that is, to regress to an earlier stage of development -- which can lead it to become resistant to treatment. Now, UCLA researchers led by Dr. Thomas Graeber have found that melanomas can be more

Twitter logoFollow CLIC
Twitter logoFollow NCATS